Australia markets closed

BiomX Inc. (PHGE)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.4080-0.0366 (-8.23%)
At close: 04:00PM EDT
0.4010 -0.01 (-1.72%)
Pre-market: 07:00AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 22.53M
Enterprise value 22.71M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)7.31
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.99

Trading information

Stock price history

Beta (5Y monthly) 1.36
52-week change 351.36%
S&P500 52-week change 322.43%
52-week high 30.8550
52-week low 30.1870
50-day moving average 30.3373
200-day moving average 30.3325

Share statistics

Avg vol (3-month) 32.72M
Avg vol (10-day) 3294.71k
Shares outstanding 555.22M
Implied shares outstanding 655.22M
Float 832.39M
% held by insiders 129.80%
% held by institutions 125.72%
Shares short (15 Apr 2024) 4155.07k
Short ratio (15 Apr 2024) 40.45
Short % of float (15 Apr 2024) 40.34%
Short % of shares outstanding (15 Apr 2024) 40.28%
Shares short (prior month 15 Mar 2024) 4442.65k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-44.90%
Return on equity (ttm)-216.99%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -24.48M
Net income avi to common (ttm)-26.17M
Diluted EPS (ttm)-0.5100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.91M
Total cash per share (mrq)0.27
Total debt (mrq)15.09M
Total debt/equity (mrq)489.84%
Current ratio (mrq)1.58
Book value per share (mrq)0.07

Cash flow statement

Operating cash flow (ttm)-21.29M
Levered free cash flow (ttm)-12.32M